8-K
filed May 29, 2026, 4:56 PM ET
ticker MNPR
CIK 0001645469
other material
confidence low
sentiment neutral
materiality 0.50
Monopar presents Phase 2 data for ALXN1840 in Wilson disease at EASL 2026
Monopar Therapeutics
- ALXN1840 (tiomolibdate choline) Phase 2 study results presented at EASL International Liver Congress 2026.
- Study evaluated effect on liver pathology and clinical symptoms in Wilson disease patients.
- No specific efficacy or safety figures provided in the 8-K text; presentation is an image exhibit.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001437749-26-018896
- form_type
- 8-K
- ticker
- MNPR
- cik
- 0001645469
- company_name
- Monopar Therapeutics
- filed_at
- 2026-05-29T20:56:34+00:00
- discovered_at
- 2026-05-29T20:57:05.252767+00:00
- generated_at
- 2026-05-29T20:57:37.883378+00:00
- sec_items
- ["7.01", "9.01"]
- event_type
- other_material
- sentiment
- neutral
- materiality_score
- 0.5
- calibrated_materiality_score
- 0.5
- confidence
- low
- secwatch_canonical_url
- https://secwatch.observer/filing/0001437749-26-018896
- json_url
- https://secwatch.observer/filing/0001437749-26-018896.json
- markdown_url
- https://secwatch.observer/filing/0001437749-26-018896.md
- text_url
- https://secwatch.observer/filing/0001437749-26-018896.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1645469/000143774926018896/0001437749-26-018896-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1645469/000143774926018896/mnpr20260529_8k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
SMC
Summit Midstream Corporation announces inaugural $35 million stock repurchase program
Summit Midstream Corp
June 1, 2026, 4:31 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
LTRX
Lantronix prices $30M common stock offering at $7.20/share; net proceeds ~$32.3M
LANTRONIX INC
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
RMR
RMR highlights $37B AUM, 40%+ EBITDA margins, and $120M liquidity in investor presentation
RMR GROUP INC.
June 1, 2026, 4:11 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
EDAP
EDAP TMS holds FocalTherics Investor Day; plans to exit ESWL and distribution segments to focus on HIFU
EDAP TMS SA
June 1, 2026, 4:05 PM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
ATRO
Astronics announces 20% Class B stock distribution to all shareholders
ASTRONICS CORP
June 1, 2026, 9:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
CABR
Caring Brands expands licensing deal for Photocil and Hair Enzyme Booster to 5-year term, new territories
Caring Brands, Inc.
June 1, 2026, 8:05 AM ET
other_material
Items 7.01, 9.01
same SEC item: 7.01, 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
GIPR
Generation Income Properties prices $5.0M public offering of 23.8M shares and warrants at $0.21/unit
GENERATION INCOME PROPERTIES, INC.
June 1, 2026, 5:27 PM ET
other_material
Items 1.01, 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
MUX
McEwen receives $49.4M dividend from Minera Santa Cruz; total 2026 dividends now $58.2M
McEwen Inc.
June 1, 2026, 5:14 PM ET
other_material
Items 8.01, 9.01
same SEC item: 9.01
same event type: other_material
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.